BIIB — BIOGEN INC. catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

4 verified catalyst event(s) for BIOGEN INC. (ticker BIIB). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-07-31 — A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-07-31 in 1mo ESTIMATED	READOUT A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB0 Phase 3 · Muscular Atrophy, Spinal	BIIB BIOGEN INC.	Nusinersen	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-09-27 in 3mo ESTIMATED	READOUT A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whethe Phase 3 · Lupus Erythematosus, Systemic	BIIB BIOGEN INC.	Litifilimab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-09-30 in 3mo ESTIMATED	READOUT A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whethe Phase 3 · Lupus Erythematosus, Systemic	BIIB BIOGEN INC.	Litifilimab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-10-20 in 4mo ESTIMATED	READOUT A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Sym Phase 2/3 · Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus	BIIB BIOGEN INC.	Litifilimab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change